Clinical trial
AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
NCT02161146 is registered in ClinicalTrials.gov with Allergan as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis
- Lead sponsor
- Allergan
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 4, 2014
- Completion date
- December 20, 2014
- Enrollment
- 240 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.